Macrogen, Lifex Biolabs to research Parkinson’s treatment – The Korea Herald

Related Articles:

• US research company Lifex works with S. Korea's Macrogen to develop Parkinson's disease treatment - Aju Business Daily February 22, 2021 US research company Lifex works with S. Korea's Macrogen to develop Parkinson's disease treatment  Aju Business Daily
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• A plutocratic proposal: iCancer February 2, 2020    Speeding up the clinical development process is a shared goal across many medical conditions (not just Parkinson’s and neurodegeneration), and there are many different approaches to achieving this that are being explored. Some of these approaches could be considered to be bordering on the unethical, but there are aspects of their structure and design that are still worthy of…
• 'Lundbeck to work with lawmakers to prevent suicide in Korea' - Korea Biomedical Review - Korea Biomedical Review September 17, 2019 'Lundbeck to work with lawmakers to prevent suicide in Korea' - Korea Biomedical Review  Korea Biomedical ReviewLundbeck, which sells anti-depressants Lexapro and Brintellix, dementia treatment Ebixa, and Parkinson's disease drug Azilect, has been one of the established ...
• Regencor and Nitrome Biosciences Announced as 2019 Amgen Golden Ticket Winners - BioSpace June 26, 2019 Regencor and Nitrome Biosciences Announced as 2019 Amgen Golden Ticket Winners  BioSpaceThe award provides priority admission or a one-year renewal for lab bench space and access to core facilities at the MBC BioLabs life sciences incubator.
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• Monthly Research Review – November 2019 November 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Giving Back & Living Well with Parkinson’s April 2, 2020 “The best way to find yourself is to lose yourself in the service of others.” – Gandhi When we ask people in our community what they do to live well, the vast majority say that giving back is at the top of their list. Whether they give back by leading support groups, participating in clinical trials, educating themselves so they…
• Monthly Research Review: Jaunary 2020 January 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2020. The post is divided into seven parts based on the type of research: Basic biology, Disease mechanism, Clinical research, New clinical trials, Clinical trial news, Other news, and…
• Access to Rehabilitation in Asian Countries: Time to Refine the Way to Referral? January 22, 2021 At the 5th World Parkinson Congress in Kyoto, Japan in 2019, I met many persons with Parkinson's disease (PwPs) from all over the world, and we discussed a variety of issues regarding the disease. One substantial problem that came up regularly was rehabilitation. Many PwPs asked me what kind of rehabilitation I recommended, how many sessions and how long is…
• PARP-kinson’s goes chlorogenic December 20, 2020 # # # # For a long time it was been reported that coffee may be able to reduce the risk of developing Parkinson’s, but the mechansim by which this association could be occurring has remained elusive. Now researchers from South Korea have discovered a biological pathway that could help to explain the protective association. It involves a protein called…
• Cancer risk in patients with Parkinson's disease in South Korea: A nationwide, population-based cohort study. June 24, 2019 Cancer risk in patients with Parkinson's disease in South Korea: A nationwide, population-based cohort study. Eur J Cancer. 2019 Jun 20;117:5-13 Authors: Park JH, Kim DH, Park YG, Kwon DY, Choi M, Jung JH, Han K Abstract INTRODUCTION: The association between Parkinson's disease (PD) and cancer development is controversial, especially in Asia. Therefore, we conducted a nationwide population-based cohort study…
• Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea. October 24, 2019 Related ArticlesPrevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea. BMC Public Health. 2019 Oct 22;19(1):1328 Authors: Han S, Kim S, Kim H, Shin HW, Na KS, Suh HS Abstract BACKGROUND: Parkinson's disease (PD) and drug-induced parkinsonism (DIP) are the major diseases of parkinsonism. To better understand parkinsonism, we aimed to assess the prevalence and incidence of PD…
• U.S. Biotechs Line Up to List in Korea Amid Jump in Share Prices - Bloomberg June 16, 2019 U.S. Biotechs Line Up to List in Korea Amid Jump in Share Prices  BloombergU.S. biotech firms are queuing up to list in South Korea, tempted by the promise of strong valuations amid a welcoming base of investors.
• 2019: Year in review December 31, 2019   In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
• 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Pedaling for Parkinson's benefits patients at Decatur Family YMCA - Herald & Review May 7, 2018 Herald & ReviewPedaling for Parkinson's benefits patients at Decatur Family YMCAHerald & ReviewPersonal trainer Penny Butts records David Stewart's heart rate and repetitions per minute during the Pedaling for Parkinson's program session at the Decatur Family YMCA Friday. Exercise can slow the progression of Parkinson's. JIM BOWLING, HERALD ...
• Hyundai Pharmaceutical Launches Korea's First Parkinson's Disease Treatment - BusinessKorea June 21, 2019 Hyundai Pharmaceutical Launches Korea's First Parkinson's Disease Treatment  BusinessKoreaHyundai Pharmaceutical announced on June 20 that it has launched Korea's first Parkinson's disease treatment Ropinirole hydrochloride (HCl).The original ...
• Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea - IT News Online February 1, 2021 Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea  IT News Online
• Eisai to launch Parkinson's disease treatment Equfina in South Korea - BSA bureau February 1, 2021 Eisai to launch Parkinson's disease treatment Equfina in South Korea  BSA bureau
• Eisai launches Parkinson's disease treatment Equfina in South Korea - BSA bureau February 2, 2021 Eisai launches Parkinson's disease treatment Equfina in South Korea  BSA bureau